Zev A. Wainberg, MD Associate Professor Of Medicine Co-Director GI Oncology Program David Geffen School of Medicine at UCLA gives an update in Gastrointestinal Cancers including KEYNOTE-059, Pembrolizumab, MSI-H KN 059, MSI-H KN 059 061, KEYNOTE 181, KEYNOTE-062, KEYNOTE 59, KEYNOTE-811, CHECKMATE-649, Javelin Gastric 100, SPOTLIGHT (FAST-2) 1L Claudin+, FIGHT 1L FGFR2, PRODIGE 24/CCTG PA.6 trial at the MOASC Summit 2020
Sponsors:
AbbVie
AMAG
AstraZeneca
Bayer
BeiGene
Clovis Oncology
Coherus
Daiichi-Sankyo
Dova Pharmaceuticals
Foundation Medicine
Jazz Pharmaceuticals
Merck
Pfizer Oncology
Puma Biotechnology
Tempus
Verastem oncology
Walgreens
Advertisement